MD Anderson Cancer Center

• by EVOMT
• 2021-07-27

The M. D. Anderson Cancer Center, founded in 1941, is located in Houston, Texas, in the southern United States. It is recognized as a high-quality cancer specialist hospital in the world. It was established in 1971 in the United States; ldquo; National Cancer Action& rdquo; One of the three earlier comprehensive cancer treatment centers designated by the plan, and one of the 39 comprehensive cancer treatment centers designated by the oncology medical association at present; It is a world-renowned cancer diagnosis, treatment, and research center.

M.D. Anderson Cancer Center has a total of more than 20000 employees, including more than 2000 doctors and more than 500 beds. Each year, it treats more than 19000 hospitalized patients in the United States and other countries, with a daily outpatient volume of 1800 person-times. Since 1990, I have been living in& ldquo; Ranking of Outstanding Hospitals in the United States; rdquo; The top 2 oncology departments in China, ranking top in the evaluation of cancer research hospitals in the United States for 8 consecutive years. Due to its outstanding performance in cancer research and clinical practice (with a five-year survival period of up to 80%), it has gradually become a more influential cancer hospital worldwide. To date, more than 79000 cancer patients have been treated at the M.D. Anderson Cancer Center, about one-third of whom are from outside Texas, and more than 110000 patients have participated in clinical research trials at the M.D. Anderson Cancer Center.

In 2008, a total of 90000 cancer patients were treated, of which 30000 were new patients, distributed in 93 countries and regions, including political and business elites from various countries.

The treatment provided by the center for cancer patients includes targeted therapy, surgery, chemotherapy, radiation and proton therapy, immunotherapy, and a combination of multiple therapies. An interdisciplinary team of experts works closely together to develop personalized treatment plans for patients.

Anderson Cancer Center invests more than $400 million annually in basic medical research, and has many research projects funded by the National Cancer Institute (NCI). In 2005, the research funding of the M.D. Anderson Cancer Center reached 342 million US dollars. At present, the center has 10 NCI advantage research projects, including brain tumor, pancreatic cancer, breast cancer, bladder cancer, prostate cancer, leukemia, ovarian cancer, endometrial cancer, lung cancer and melanoma. Every year, more than 1100 clinical residents receive professional training in cancer research and treatment at the MD Anderson Cancer Center& nbsp;

Anderson Cancer Center has been providing oncologists around the world with the opportunity to learn global advanced technology for many years. Nowadays, many oncologists from well-known hospitals in China have come to Anderson Cancer Center for further study.